Search by Drug Name or NDC

NDC 00527-3162-32 Olanzapine 10 mg/1 Details

Olanzapine 10 mg/1

Olanzapine is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lannett Company, Inc.. The primary component is OLANZAPINE.

MedlinePlus Drug Summary

Olanzapine is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in adults and teenagers 13 years of age and older. It is also used to treat bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods) in adults and teenagers 13 years of age and older. Olanzapine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

Related Packages: 00527-3162-32
Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Olanzapine

Product Information

NDC	00527-3162
Product ID	0527-3162_002da62b-aec3-8e2a-e063-6294a90a5efc
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Olanzapine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Olanzapine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, ORALLY DISINTEGRATING
Route	ORAL
Active Ingredient Strength	10
Active Ingredient Units	mg/1
Substance Name	OLANZAPINE
Labeler Name	Lannett Company, Inc.
Pharmaceutical Class	Atypical Antipsychotic [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA208146
Listing Certified Through	2024-12-31

Package

NDC 00527-3162-32 (00527316232)

Pricing Information	N/A
NDC Package Code	0527-3162-32
Billing NDC	00527316232
Package	30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0527-3162-32)
Marketing Start Date	2023-07-01
NDC Exclude Flag	N